Harvard Women's Health Watch

New cervical cancer vaccine highly promising, but questions remain

Studies of the cervical cancer vaccine found that it was most effective when given before the start of sexual activity, but the benefits and risks of the vaccine over time are still not fully known.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In